PATENT CLAIM ANALYSIS

Application Number: 15923275
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "005500"]

Abstract:
This invention relates to treating gastrointestinal dysfunction with erythropoietin (EPO) or its analog.

Claim (Index 19):
The method of  claim 18 , comprising administering erythropoietin or the analog to the subject over a treatment period of 24 hours to years.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15136160', '13073275', '09717053', '15703457', '09716960']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7539192683434331
- 35 USC 102 Novelty (BERT): 0.5064306186430985
- Combined Prediction Score: 0.7291704033733998
- Mean Citation Score: 210.323432
- Max Citation Score: 221.60922
- Similarity Product: 135.26142256965994

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test